Niagen Bioscience(DE:OCD1)
€1.88-0.01 (-0.53%)
DE:OCD1
Niagen Bioscience earnings date
€1.88
At close:-0.01 (-0.53%)
Niagen Bioscience (OCD1) Q4 2019 Earnings Report
2 Followers
DE:OCD1 Q4 2019 EPS Results
- Actual EPS
- -EUR 0.10
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.13
DE:OCD1 Q4 2019 Revenue Results
- Actual Revenue
- EUR 11.72M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +44.36%
Earnings Announcement Details
- Quarter
- Q4 2019
- Date
- 03/10/2020
- Time
- After Close
- Conference Call
- Tuesday, March 10, 2020
DE:OCD1 Upcoming Earnings
Niagen Bioscience's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q4 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OCD1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | -0.02- | 0.04 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.01-0.01 | 0.04 | -120.00% (-0.05) | |
| Aug 04, 2026 | 2026 (Q2) | 0.010.01 | 0.04 | -75.00% (-0.03) | |
| May 06, 2026 | 2026 (Q1) | 0.060.06 | 0.05 | 16.67% (+0.01) | |
| Mar 04, 2026 | 2025 (Q4) | 0.020.04 | 0.08 | -44.44% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | 0.020.04 | 0.03 | 72.41% (+0.02) | |
| Aug 06, 2025 | 2025 (Q2) | 0.010.04 | 0 | ― | |
| May 07, 2025 | 2025 (Q1) | 0.020.05 | -0.01 | 700.00% (+0.06) | |
| Mar 04, 2025 | 2024 (Q4) | 0.020.08 | 0 | ― | |
| Oct 31, 2024 | 2024 (Q3) | 0.010.03 | 0 | 480.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
